UNI MEDICAL (02666) announced that its wholly-owned subsidiary, China Universal Leasing Co., Ltd., has received approval from the China Securities Regulatory Commission to issue public corporate bonds in China targeting qualified investors, with a total principal amount of up to RMB8 billion. As of the date of this announcement, the remaining quota for these bonds stands at RMB5.4 billion.
The bonds will be issued in tranches, with the fourth tranche in 2025 having a principal amount not exceeding RMB1 billion (inclusive). The bonds will have a base tenor of five years, featuring issuer redemption options at the end of the third and fourth years, coupon rate adjustment options, and investor put options.
Comments